Table 3. Multiple regressions of EGF rs2237051 and serum EGF for risk of GAgP.
Exposure | Adjust I OR (95% CI) |
P-value | Adjust II OR (95% CI) |
P-value |
---|---|---|---|---|
Genotype of rs2237051 | ||||
AG/GG (N = 195) | Ref. | Ref. | ||
AA (N = 159) | 1.64 [1.06–2.54] | 0.0263* | 1.65 [1.06–2.57] | 0.0264* |
Serum EGF, pg/ml | 1.17 [1.13–1.21] | <0.0001* | 1.18 [1.14–1.22] | <0.0001* |
Notes:
P < 0.05, statistical significance.
Model I was adjusted for age and gender.
Model II was adjusted for age, gender and BMI.
Data were presented as OR (95% CI), outcome: Risk of GAgP.
Exposure: rs2237051; serum EGF.